Edwards Lifesciences Is Poised for Another Year of Robust Growth Thanks to TAVR
Edwards Lifesciences finished off 2017 in strong fashion, and we expect to moderately raise our fair value estimate to reflect margin expansion from favorable product mix shifts and the lower-than-expected effective tax rate, as well as the time value of money. We remain confident in Edwards’ narrow economic moat as the firm prepares to launch its Sapien 3 Ultra delivery system in Europe and the U.S. this year, and in European regulatory approval for its Centera self-expanding TAVR product. The ...
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.